SYNOVUS FINANCIAL CORP - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$1,000
-50.0%
3330.0%0.00%
Q4 2019$2,0000.0%3330.0%0.00%
Q3 2019$2,0000.0%3330.0%0.00%
Q2 2019$2,0000.0%3330.0%0.00%
Q1 2019$2,000
+100.0%
3330.0%0.00%
Q4 2018$1,000
-50.0%
3330.0%0.00%
Q3 2018$2,0003330.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders